SCHEMBL12235877

SCHEMBL12235877

CN(CNc1ccccc1)c1ccc(C=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.47
CYP2A13 Q16696 1/20 0.47
ALDH1A1 P00352 6/20 0.44
ALDH3A1 P30838 1/20 0.44
ALDH1A3 P47895 1/20 0.44
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NOX1 Q9Y5S8 1/20 0.37
RELA Q04206 1/20 0.37
MMP13 P45452 2/20 0.35
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668864 0.82 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL4049989 0.75 CYP2A6 (0.52) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL13645995 0.73 CYP2A6 (0.64) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL2514420 0.73 ALDH1A1 (0.65) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
Benzaldehyde SCHEMBL28092165 0.72 L3MBTL1 (0.52) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
Hydrazobenzene SCHEMBL27601693 0.72 ALDH1A1 (0.70) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
Dimethylamine SCHEMBL7601785 0.72 ALDH1A1 (0.59) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL27790779 0.71 CYP2A6 (0.52) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL17508122 0.71 CRHBP (0.57) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
Benzaldehyde SCHEMBL28191631 0.71 CYP2A6 (0.83) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110263540-A1 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263540-A1 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MRPS27, MRPS22, MRPS23 CYP2A6 4265/4885CYP2A13 4563/4885ALDH1A1 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.